- Filed
- Oct 20, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 14, 2025 | 744.44M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 743.42M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 741.39M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 726.66M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 712.17M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $493K |
| Capex | Q3 2025 · Sep 30, 2024 | $125K |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$220.99M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$93.43M |
| Short Term Investments | Q3 2025 · Sep 30, 2025 | $0 |
| Short Term Investments | Q3 2025 · Dec 31, 2024 | $307.49M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $238.55M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $104.86M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2024 | $93.78M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $192.26M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $259.44M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $344.33M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $388.75M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $437.92M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $195.08M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $44.21M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $77.69M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $64.93M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $41.73M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $69.47M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $46.81M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $246.47M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $423.75M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $261.73M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $435.56M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.31 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$1.16 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.08 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.22 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.31 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$1.16 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.08 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.22 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $103.12M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $479.12M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $20.65M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $45.98M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$231.79M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$860.41M |
| Net Income | Q3 2025 · Jun 30, 2025 | −$565.71M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$62.91M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$56.25M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$160.11M |
| Net Income | Q3 2025 · Jun 30, 2024 | −$60.39M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$43.47M |